oleanolic acid has been researched along with Colitis in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 9 (69.23) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| An, Y; Li, J; Li, M; Li, P; Ren, J; Wu, M; Xie, Y; Xiong, W; Xue, H; Yan, D; Zhong, G | 1 |
| Gong, Y; Huang, ZJ; Mou, Y; Qiao, X; Wen, XD; Zhang, YH | 1 |
| Meng, LJ; Wang, N; Xia, YC; Yang, L; Zhang, LC; Zhou, F | 1 |
| Bento, AF; Calixto, JB; Claudino, RF; Marcon, R; Matos, I | 1 |
| Fitzpatrick, LR; Liby, KT; Small, JS; Stonesifer, E | 1 |
| Choi, SH; Fink, S; Kim, BG; Letterio, JJ; Markowitz, SD; Robinson, J; Sporn, MB; Yan, M | 1 |
| Chan, JY; Khazaeli, M; Lau, WL; Liu, SM; Ni, Z; Pahlevan, S; Vaziri, ND; Yuan, J | 1 |
| Kang, GD; Kim, DH; Lim, S | 1 |
| Bento, AF; Calixto, JB; Figueiredo, CP; Hara, DB; Mazzuco, TL; Vitor, CE | 1 |
| Han, MJ; Kim, DH; Lee, IA; Park, YJ; Yeo, HK | 1 |
| Joh, EH; Kim, DH | 1 |
| Han, MJ; Hyam, SR; Jang, SE; Jeong, JJ; Joh, EH; Kim, DH | 1 |
| Alcaraz, MJ; Busserolles, J; D'Auria, MV; Gomez-Paloma, L; Payá, M | 1 |
13 other study(ies) available for oleanolic acid and Colitis
| Article | Year |
|---|---|
Saikosaponin-d ameliorates dextran sulfate sodium-induced colitis by suppressing NF-κB activation and modulating the gut microbiota in mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis; Colitis, Ulcerative; Cytokines; Dextran Sulfate; Disease Models, Animal; Feces; Gastrointestinal Microbiome; Humans; Inflammation Mediators; Male; Mice; Mice, Inbred BALB C; Mucins; NF-kappa B; Oleanolic Acid; Saponins; Signal Transduction | 2020 |
Identification of a new azoreductase driven prodrug from bardoxolone methyl and 5-aminosalicylate for the treatment of colitis in mice.
Topics: Animals; Colitis; Mesalamine; Mice; Nitroreductases; Oleanolic Acid; Prodrugs | 2021 |
Saikosaponin A protects against dextran sulfate sodium-induced colitis in mice.
Topics: Animals; Anti-Inflammatory Agents; Colitis; Colon; Dextran Sulfate; Interleukin-1beta; Liver X Receptors; Male; Mice, Inbred C57BL; NF-kappa B; Oleanolic Acid; Saponins; Tumor Necrosis Factor-alpha | 2019 |
Preventive and therapeutic oral administration of the pentacyclic triterpene α,β-amyrin ameliorates dextran sulfate sodium-induced colitis in mice: the relevance of cannabinoid system.
Topics: Administration, Oral; Amidohydrolases; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Asialoglycoproteins; Body Weight; Cannabinoids; CD18 Antigens; Cell Adhesion Molecules; Chemokines; Colitis; Colon; Dextran Sulfate; Intercellular Adhesion Molecule-1; Interleukin-1beta; Interleukin-4; Ki-67 Antigen; Lectins, C-Type; Male; Membrane Proteins; Mice; Oleanolic Acid; P-Selectin; Peroxidase; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; RNA, Messenger; Tumor Necrosis Factor-alpha; Up-Regulation; Vascular Cell Adhesion Molecule-1 | 2013 |
The synthetic triterpenoid (CDDO-Im) inhibits STAT3, as well as IL-17, and improves DSS-induced colitis in mice.
Topics: Animals; Colitis; Dextran Sulfate; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Imidazoles; Inflammation; Inhibitory Concentration 50; Interleukin-17; Interleukin-6; Male; Mice; Mice, Inbred BALB C; Oleanolic Acid; Spleen; STAT3 Transcription Factor; Time Factors; Trinitrobenzenesulfonic Acid | 2014 |
Synthetic triterpenoid induces 15-PGDH expression and suppresses inflammation-driven colon carcinogenesis.
Topics: Animals; Anticarcinogenic Agents; Carcinogenesis; Colitis; Colonic Neoplasms; Cyclooxygenase 2; Enzyme Induction; Hydroxyprostaglandin Dehydrogenases; Intestinal Mucosa; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide Synthase Type II; Oleanolic Acid; Smad4 Protein; STAT Transcription Factors | 2014 |
Role of Nrf2 dysfunction in uremia-associated intestinal inflammation and epithelial barrier disruption.
Topics: Animals; Anti-Inflammatory Agents; Biomarkers; Case-Control Studies; Colitis; Colon; Disease Models, Animal; Inflammation Mediators; Intestinal Mucosa; Male; Nephrectomy; NF-E2-Related Factor 2; Oleanolic Acid; Oxidative Stress; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Signal Transduction; Tight Junction Proteins; Tight Junctions; Uremia | 2015 |
Oleanolic acid ameliorates dextran sodium sulfate-induced colitis in mice by restoring the balance of Th17/Treg cells and inhibiting NF-κB signaling pathway.
Topics: Animals; Caco-2 Cells; Colitis; Colon; Dextran Sulfate; Humans; Interleukin-17; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Nuclear Receptor Subfamily 1, Group F, Member 3; Oleanolic Acid; Peroxidase; Signal Transduction; Spleen; T-Lymphocytes, Regulatory; Th17 Cells | 2015 |
Therapeutic action and underlying mechanisms of a combination of two pentacyclic triterpenes, alpha- and beta-amyrin, in a mouse model of colitis.
Topics: Animals; Colitis; Disease Models, Animal; Drug Therapy, Combination; Male; Mice; Oleanolic Acid; Pentacyclic Triterpenes; Trinitrobenzenesulfonic Acid | 2009 |
Soyasaponin I attenuates TNBS-Induced colitis in mice by inhibiting NF-κB pathway.
Topics: Animals; Colitis; Cyclooxygenase 2; Glycine max; Humans; Interleukin-1; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; NF-kappa B; Oleanolic Acid; Plant Extracts; Saponins; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2010 |
Kalopanaxsaponin A ameliorates experimental colitis in mice by inhibiting IRAK-1 activation in the NF-κB and MAPK pathways.
Topics: Animals; Anti-Inflammatory Agents; Colitis; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Inflammation Mediators; Interleukin-1 Receptor-Associated Kinases; Macrophages, Peritoneal; Male; Mice; Mice, Inbred ICR; Mitogen-Activated Protein Kinases; NF-kappa B; Oleanolic Acid; Saponins; Sulfasalazine | 2011 |
Echinocystic acid, a metabolite of lancemaside A, inhibits TNBS-induced colitis in mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Codonopsis; Colitis; Colon; Cytokines; Humans; Inflammation Mediators; Lipopolysaccharides; Macrophages, Peritoneal; Male; Medicine, Chinese Traditional; Mice; Mice, Inbred ICR; NF-kappa B; Oleanolic Acid; Protein Binding; Rhizome; Saponins; Signal Transduction; Toll-Like Receptor 4; Trinitrobenzenesulfonic Acid | 2013 |
Protection against 2,4,6-trinitrobenzenesulphonic acid-induced colonic inflammation in mice by the marine products bolinaquinone and petrosaspongiolide M.
Topics: Animals; Anti-Inflammatory Agents; Calcium-Binding Proteins; Colitis; Cyclooxygenase 2; Dysidea; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Immunohistochemistry; Inflammatory Bowel Diseases; Interleukin-1; Male; Membrane Glycoproteins; Membrane Proteins; Mice; Mice, Inbred BALB C; Nerve Tissue Proteins; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oleanolic Acid; Prostaglandin-Endoperoxide Synthases; Sesquiterpenes; Synaptotagmin I; Synaptotagmins; Trinitrobenzenesulfonic Acid | 2005 |